-
IMPACT OF COMORBIDITIES ON SELF-REPORTED QUALITY-OF-LIFE IN US ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A POOLED ANALYSIS OF THE 2016-2022 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Feb 25, 2026, 14:42 PM -
REAL-WORLD FRONT-LINE USE OF ENFORTUMAB VEDOTIN - PEMBROLIZUMAB (EV+P) AFTER ADJUVANT NIVOLUMAB IN ADVANCED UROTHELIAL CANCER(AUC)
Feb 25, 2026, 14:42 PM -
HEALTHCARE COST, RESOURCE USE, AND ECONOMIC MODELS OF CISPLATIN-INELIGIBLE MUSCLE-INVASIVE BLADDER CANCER PATIENTS (MIBC)
Feb 25, 2026, 14:42 PM -
INTEGRATING RCT AND RWD FOR LONG-TERM NEONATAL OUTCOME EVALUATION: LESSONS FROM THE PRIME STUDY
Feb 25, 2026, 14:42 PM -
TRANSLATION AND PSYCHOMETRIC EVALUATION OF THE YORUBA VERSION OF IBADAN LOW-BACK PAIN DISABILITY QUESTIONNAIRE
Feb 25, 2026, 14:42 PM -
CHANGES IN BREAST CANCER SCREENING PREVALENCE FOLLOWING UPDATED USPSTF MAMMOGRAPHY GUIDELINES: DESCRIPTIVE ANALYSIS USING MARKETSCAN TREATMENT PATHWAYS
Feb 25, 2026, 14:42 PM -
EXAMINING PLAN-LEVEL BID DEVIATIONS IN MEDICARE PART D: EVIDENCE FROM 2016-2025
Feb 25, 2026, 14:42 PM -
EVOLUTION OF AI VALUE IN CHINESE CLINICAL PRACTICE: A 2025 SURVEY AND CASE SERIES ON PHYSICIAN-PRIORITIZED APPLICATIONS
Feb 25, 2026, 14:42 PM -
META-ANALYSIS OF QUALITY OF LIFE AMONG PATIENTS WITH HEPATITIS C WITH OR WITHOUT SUSTAINED VIROLOGICAL RESPONSE
Feb 25, 2026, 14:42 PM -
HEREDITARY ANGIOEDEMA IN MEXICO: ESTIMATING THE ECONOMIC BURDEN AND RESOURCE UTILIZATION IN PUBLIC HEALTHCARE
Feb 25, 2026, 14:42 PM -
ALTERNATIVE ANALYTICAL APPROACHES TO INVESTIGATING THE ASSOCIATION BETWEEN TIMELINESS OF LUNG CANCER TREATMENT AND SURVIVAL
Feb 25, 2026, 14:42 PM -
A STRUCTURED FRAMEWORK FOR CATEGORISING UNMET NEED IN HTA: APPLICATION TO SOLID TUMOR ASSESSMENTS ACROSS EIGHT OECD COUNTRIES
Feb 25, 2026, 14:42 PM -
A QUALITATIVE STUDY TO EXPLORE PATIENT PERSPECTIVES ON FUTURE GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY (LGMD) SARCOGLYCANOPATHY SUBTYPES 2E/R4, 2D/R3, AND 2C/R5
Feb 25, 2026, 14:42 PM -
RACING TO MARKET: WHAT HAPPENS AFTER FDA EXPEDITED APPROVAL IN ORPHAN DRUGS?
Feb 25, 2026, 14:42 PM -
IMPACT OF GOLD-GUIDED PHARMACIST-LED PHARMACEUTICAL CARE ON CLINICAL OUTCOMES AND QUALITY OF LIFE IN COPD: A PROSPECTIVE RANDOMIZED TRIAL
Feb 25, 2026, 14:42 PM -
DESCRIPTION OF THE CHARACTERISTICS AND BURDEN OF NEUROFIBROMATOSIS TYPE 1 WITH PLEXIFORM NEUROFIBROMA IN A SAMPLE OF ADULT PATIENTS IN THE USA: RESULTS FROM A REAL-WORLD SURVEY
Feb 25, 2026, 14:42 PM -
CONSENSUS ON BARRIERS AND UNMET NEEDS IN HEMOPHILIA CARE IN BRAZIL: A MODIFIED DELPHI STUDY
Feb 25, 2026, 14:42 PM -
INCIDENCE AND MORTALITY RATES OF RECURRENT ISCHEMIC STROKES AMONG MEDICARE FEE-FOR-SERVICE BENEFICIARIES IN THE UNITED STATES
Feb 25, 2026, 14:42 PM -
THE IMPACT OF GLYCEMIC CONTROL AND MEDICATION ADHERENCE ON HOSPITALIZATION RISK IN TYPE 2 DIABETES: A LONGITUDINAL REAL-WORLD EVIDENCE STUDY FROM THE LITHUANIAN NATIONAL HEALTH INSURANCE FUND ADMINISTRATIVE DATA
Feb 25, 2026, 14:42 PM -
CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN CISPLATIN ELIGIBLE VERSUS CISPLATIN INELIGIBLE MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH INTENT FOR RESECTION: A MULTICOUNTRY RETROSPECTIVE CHART REVIEW IN EUROPE
Feb 25, 2026, 14:42 PM
